What we're reading, November 4, 2016: Public option gains momentum among Democrats; a new Veterans Affairs clinic is dedicated to women's health; and Sutter Health in California attempts to prevent lawsuits.
Both Democrats and Republicans agree that the Affordable Care Act is flawed; however, the 2 parties disagree how to move forward. According to The Wall Street Journal, Democratic legislators are increasingly looking at creating a government option in health insurance. This option differs from a single-payer system, where the government’s insurance covers everyone. Instead, a public option can be nationwide, state-based, or only limited to areas where there are few insurance options. Hillary Clinton is a longtime supporter of the public option, while Donald Trump has come out against it.
A new Veterans Affairs clinic in Pennsylvania has been dedicated to provide specialized care for female veterans. Currently, 10% of veterans are women and that number is growing; the new clinic provides more privacy and security for these patients, reported Times Leader. In addition to the regular benefits female veterans receive, the women’s center will also provide specialty care that includes reproductive healthcare, such as maternity care and infertility evaluation and some treatment.
In California, some companies are being asked to sign a contract to waive their rights to sue hospitals in Sutter Health’s system. NPR reported that for companies that do not sign the contract, employees will not have discounted in-network prices for using Sutter’s network. Sutter Health already charges higher prices than other hospitals in the state, according to research.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Study Links COVID-19 Pandemic to Rise in Neoadjuvant Chemotherapy for Ovarian Cancer in US
April 17th 2024There was greater use of neoadjuvant chemotherapy among US patients with ovarian cancer (OC) during the COVID-19 pandemic to reduce potential COVID-19 exposure and cancer treatment-related complications.
Read More